Delivery Order SPE2DR25D1017-SPE2DR26F9GTB
Award Date 3/13/26
Potential Completion Date 3/16/26
Potential Value $3.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $5,064 delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Deferasirox 500 mg tablets for suspension (30-count). The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and is non-competitive (no...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for deferasirox 360 mg tablets (30-count), with a ceiling value of $3,005.10.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $43,387.99. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg tablets (30-count) with a ceiling value of $48,938.95. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,482.69 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Deferasirox 360 mg tablets (30-count units). The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through...
- The Defense Logistics Agency awarded a $21,649.14 delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units) under a firm fixed-price contract with an ultimate completion date of December 3, 2025. This non-competitive set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 360 mg Deferasirox tablets (30-count units) on May 16, 2025, with a ceiling value of $5,673.37 and an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award represents a competitive, non-set-aside...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $12,194.10 to Amerisourcebergen Drug Corporation for 4561450755 DEFERASIROX 500 MG tablets for suspension. The order is for 30 bottles of the oral suspension to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 11, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...